Finding Drug Repurposing Candidates for Neurodegenerative Diseases using Zebrafish Behavioral Profiles

Drug repurposing can accelerate drug development while reducing the cost and risk of toxicity typically associated with de novo drug design. Several disorders lacking pharmacological solutions and exhibiting poor results in clinical trials - such as Alzheimer’s disease (AD) - could benefit from a co...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández, Thaís Del Rosario, Gore, Sayali V, Kreiling, Jill A, Creton, Robbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515830/
https://www.ncbi.nlm.nih.gov/pubmed/37745452
http://dx.doi.org/10.1101/2023.09.12.557235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515830/
https://www.ncbi.nlm.nih.gov/pubmed/37745452
http://dx.doi.org/10.1101/2023.09.12.557235

Ejemplares similares